BG
CSII

Bollard Group’s Cardiovascular Systems, Inc. CSII Stock Holding History

Bollard Group’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,312
Closed -$52K – 430
2022
Q1 		$52K Hold
2,312
– – ﹤0.01% 338
2021
Q4 		$43K Hold
2,312
– – ﹤0.01% 359
2021
Q3 		$76K Hold
2,312
– – ﹤0.01% 311
2021
Q2 		$99K Hold
2,312
– – ﹤0.01% 286
2021
Q1 		$89K Hold
2,312
– – ﹤0.01% 289
2020
Q4 		$101K Hold
2,312
– – ﹤0.01% 267
2020
Q3 		$91K Hold
2,312
– – ﹤0.01% 261
2020
Q2 		$73K Buy
+2,312
New +$86.4K ﹤0.01% 296

Other funds holding CSII

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Bollard Group's CSII Position: Q2 2022 in Review

Bollard Group sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2022, closing a stake of 2,312 shares — an estimated $52K sold.

Bollard Group first reported a position in CSII in Q2 2020 and held it in 8 quarters. The position peaked at $101K in Q4 2020. 158 funds tracked by Wall St. Rank hold CSII as of Q2 2022.

  • Bollard Group reported no remaining Cardiovascular Systems, Inc. position as of Q2 2022 after selling out during the quarter.
  • Bollard Group sold 2,312 Cardiovascular Systems, Inc. shares in Q2 2022, an estimated $52K.
  • Bollard Group first reported a position in Cardiovascular Systems, Inc. in Q2 2020 and held it in 8 quarters.
  • Bollard Group's Cardiovascular Systems, Inc. position peaked at $101K in Q4 2020.
  • 158 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2022.

Based on Bollard Group's 13F filing for Q2 2022, filed 12 Aug 2022.